RankAlpha logo
Back to Rankings

AKBA

Akebia TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
AKBA vs peer average
42/100
AKBA vs. peer average (D vs. C)
Grade spread
A 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

NVCT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $252.26M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerNVCTNuvectis
AKBA
Akebia Therapeutics
NVCT
Nuvectis
Grade
D
C
Momentum
16
88
Value
66
41
Sentiment
-
35
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs NVCT

AKBA / NVCT
Grade Position
Below peers
AKBA vs. peer average (D vs. C)
42/100
Momentum
16
NVCT
Value
66
AKBA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AKBA
1
NVCT
Nuvectis Pharma Inc Common
C
60/100
-1
2
CLLS
Cellectis SA ADR
A
100/100
-3
3
ACIU
AC Immune SA Common
D
40/100
Even
4
MGNX
MacroGenics Inc Common
A
100/100
-3
5
TRDA
Entrada Therapeutics Inc Common
F
20/100
+1
NVCT is the first peer returned for this comparison set.